retatrutide dosing clinical trial Dosing: Early Insights on How It Might Work Retatrutide—A Game Changer in Obesity

Shahs study, which included people who had type 1 and obesity, was a randomized, double-blinded study in patients who use an artificial pancreas to control their blood sugar

Chou SY, Chan L, Chung CC, Chiu JY, Hsieh YC, Hong CT

The subsequent success of GLP-1 receptor agonists, despite early gastrointestinal intolerance and safety concerns, illustrates how such signals may be manageable through improved formulation and dosing rather than indicative of fundamental biological unsuitability

Dosage and Administration Errors The lack of standardization means there is a much-needed margin of error for dosages, so with this newfound freedom comes the increased possibility of contamination

Unlike GLP-1, GIP has not been found to possess a similar neural signaling mechanism for decelerating gastric emptying (54, 162)

With 50%+ of users discontinuing GLP-1s due to cost and 36% due to side effects, this low and slow approach could potentially help more patients stay on therapy and achieve real results